Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Crossover Comparative Bioavailability Study of Bupropion Hydrochloride Modified Release Tablet 300mg In Healthy Adult Subjects / Fasting State

NCT05160090 is registered in ClinicalTrials.gov with Alembic Pharmaceuticals Ltd. as lead sponsor.

NCT NCT05160090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05160090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Crossover Comparative Bioavailability Study of Bupropion Hydrochloride Modified Release Tablet 300mg In Healthy Adult Subjects / Fasting State
Lead sponsor
Alembic Pharmaceuticals Ltd.
Phase
Phase 1
Overall status
Completed
Start date
January 18, 2020
Completion date
February 5, 2020
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence